Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Transient and Sustained Bacterial Adaptation following Repeated Sublethal Exposure to Microbicides and a Novel Human Antimicrobial Peptide

Sarah Forbes, Curtis B. Dobson, Gavin J. Humphreys, Andrew J. McBain
Sarah Forbes
aManchester Pharmacy School, The University of Manchester, Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis B. Dobson
bFaculty of Life Sciences, The University of Manchester, Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin J. Humphreys
aManchester Pharmacy School, The University of Manchester, Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. McBain
aManchester Pharmacy School, The University of Manchester, Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.03364-14
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Bacterial biofilm formation before (■) and after (□) long-term exposure to ApoEdpL-W (A), chlorhexidine (B), PHMB (C), and triclosan (D). Data represent changes in biofilm formation in selected bacteria that underwent >4-fold changes in the MBCs following microbicide exposure. *, significant change in result (P < 0.001). Data show the mean levels of biofilm-bound crystal violet for P0 and P10 samples taken from two separate experiments each with three technical replicates.

Tables

  • Figures
  • TABLE 1

    MICs and minimum bactericidal concentrations of bacteria before and after treatment with cetrimidea

    Test bacteriumMIC (μg/ml)MBC (μg/ml)
    Before exposureP10X10Before exposureP10X10
    Bacillus cereus7.314.57.314.548.3 (8)29
    Burkholderia cepacia38.7 (17)38.6 (8)29116232232
    Chryseobacterium indologenes12.1 (4)14.514.5292929
    Corynebacterium xerosis3.63.63.614.59.7 (4)14.5
    Enterococcus faecalis12.1 (4)14.514.52938.7 (16)58
    Escherichia coli29.17 (8)11629116464116
    Klebsiella pneumoniae29.3 (8)11629295858
    Micrococcus luteus14.57.3 (33)14.55819.3 (8)29
    Pseudomonas aeruginosa232232232464464464
    Serratia marcescens24.2 (8)37.3 (14)2937.3 (14)11658
    Staphylococcus aureus4.8 (2)6 (2)7.37.314.57.3
    Staphylococcus capitis3.67.37.314.57.37.3
    Staphylococcus caprae0.91.81.814.514.514.5
    Staphylococcus epidermidis1.87.31.83.67.37.3
    Staphylococcus haemolyticus0.47.37.314.514.514.5
    Staphylococcus lugdunensis0.43.63.62914.529
    Staphylococcus warneri4.8 (2)6.1 (2)7.3193.3232116
    Stenotrophomonas maltophilia19.3 (8)29295824.2 (8)58
    • ↵a Data show the mean MICs and minimum bactericidal concentrations of bacteria before and after microbicide exposure in μg/ml and represent samples taken from two separate experiments each with three technical replicates. For data that varied between replicates, SDs are given in parentheses. Bold type indicates a ≥4-fold change when comparing P0 to P10 and X10 values.

  • TABLE 2

    MICs and minimum bactericidal concentrations of bacteria before and after treatment with chlorhexidinea

    Test bacteriumMIC (μg/ml)MBC (μg/ml)
    Before exposureP10X10Before exposureP10X10
    Bacillus cereus14.514.514.529232116
    Burkholderia cepacia3.6297.326.6 (6)232116
    Chryseobacterium indologenes7.37.37.37.314.57.3
    Corynebacterium xerosis3.3 (1)3.63.621.8 (8)14.514.5
    Enterococcus faecalis3.624.2 (8)3.626.6 (6)5829
    Escherichia coli6.7 (1)7.37.313.3 (3)2929
    Klebsiella pneumoniae2.1 (1)14.514.516.3 (5)58116
    Micrococcus luteus3.63.63.614.57.314.5
    Pseudomonas aeruginosa7.314.57.314.52914.5
    Serratia marcescens12.1 (4)1165824.2 (7)232116
    Staphylococcus aureus8.5 (4)3.63.613.3 (4)5829
    Staphylococcus capitis3.66 (2)7.314.514.529
    Staphylococcus caprae3.63.67.3292929
    Staphylococcus epidermidis13.3 (3)9.7 (4)14.533.8 (12)24.2(8)29
    Staphylococcus haemolyticus1.4 (0.4)3 (1)1.84.2(1)14.57.3
    Staphylococcus lugdunensis0.93.64.8 (2)1.7 (0.3)48.3 (17)58
    Staphylococcus warneri292929585858
    Stenotrophomonas maltophilia4.8 (2)292914.55858
    • ↵a See Table 1 footnote for explanation of data.

  • TABLE 3

    MICs and minimum bactericidal concentrations of bacteria before and after treatment with polyhexamethylene biguanidea

    Test bacteriumMIC (μg/ml)MBC (μg/ml)
    Before exposureP10X10Before exposureP10X10
    Bacillus cereus582958585858
    Burkholderia cepacia5858291165858
    Chryseobacterium indologenes0.93.61.81.814.57.3
    Corynebacterium xerosis2.7 (1)7.32.2 (0.4)21.8 (8)7.314.5
    Enterococcus faecalis1.814.59.77.3297.3
    Escherichia coli13.3 (3)24.2 (8)7.326.6 (6)5814.5
    Klebsiella pneumoniae7.3299.7 (4)2996.7 (34)58
    Micrococcus luteus1.87.31.87.314.57.3
    Pseudomonas aeruginosa31.3 (6)5829116232116
    Serratia marcescens38.7 (15)292938.7 (15)2929
    Staphylococcus aureus7.37.37.352 (11)5858
    Staphylococcus capitis1.1 (0.3)6 (2)1.87.348.3 (17)7.3
    Staphylococcus caprae6.7 (2)4.9 (2)7.32938.7 (17)29
    Staphylococcus epidermidis3 (1)14.53.626.6 (6)38.7 (17)29
    Staphylococcus haemolyticus1.87.31.8295829
    Staphylococcus lugdunensis3.67.31.85.4 (2)48.3 (17)7.3
    Staphylococcus warneri3.66 (2)3.6295829
    Stenotrophomonas maltophilia3 (1)3.63.6292929
    • ↵a See Table 1 footnote for explanation of data.

  • TABLE 4

    MICs and minimum bactericidal concentrations of bacteria before and after treatment with triclosana

    Test bacteriumMIC (μg/ml)MBC (μg/ml)
    Before exposureP10X10Before exposureP10X10
    Bacillus cereus7.3297.35811658
    Burkholderia cepacia232116232464464464
    Chryseobacterium indologenes0.93.60.93.67.33.6
    Corynebacterium xerosis7.3587.37.3587.3
    Enterococcus faecalis3.3 (1)583.3 (1)3.3 (1)96.7 (34)14.5
    Escherichia coli0.5294.820.52914.5
    Klebsiella pneumoniae0.911614.52911614.5
    Micrococcus luteus7.312.1 (4)3.637.314.57.3
    Pseudomonas aeruginosaNSbNSNSNSNSNS
    Serratia marcescens232116232232464232
    Staphylococcus aureus0.2292.41.85812.1 (4)
    Staphylococcus capitis24.2 (8)2914.52977.3 (33)29
    Staphylococcus caprae12.3 (4)2914.524.2 (8)5829
    Staphylococcus epidermidis13.3(3)38.7 (17)14.553.2 (12)11658
    Staphylococcus haemolyticus0.4290.47.3587.3
    Staphylococcus lugdunensis0.9290.97.3587.3
    Staphylococcus warneri0.924.2 (8)0.914.538.7 (17)14.5
    Stenotrophomonas maltophilia14.523214.55846348.3
    • ↵a See Table 1 footnote for explanation of data.

    • ↵b NS, nonsusceptible (MIC/MBC ratio of >1,000 μg/ml).

  • TABLE 5

    MICs and minimum bactericidal concentrations of bacteria before and after treatment with apoEdpL-Wa

    Test bacteriumMIC (μg/ml)MBC (μg/ml)
    Before exposureP10X10Before exposureP10X10
    Bacillus cereus14.52929585858
    Burkholderia cepacia292929585858
    Chryseobacterium indologenes1.4 (0.4)14.53.633 (1)14.514.5
    Corynebacterium xerosis14.52914.52924.2 (8)29
    Enterococcus faecalis7.329297.323258
    Escherichia coli5829295896.729
    Klebsiella pneumoniae7.3297.37.32912.1 (4)
    Micrococcus luteus7.312.1 (4)7.314.52929
    Pseudomonas aeruginosa14.548.3 (17)14.558119.358
    Serratia marcescens232464232464464464
    Staphylococcus aureus7.33.67.314.52914.5
    Staphylococcus capitis13.3 (3)24.2 (8)14.5299.829
    Staphylococcus caprae0.919.3 (8)3.63.6297.3
    Staphylococcus epidermidis0.97.33.64.25858
    Staphylococcus haemolyticus1.3 (1)3.63.63.62938.7 (8)
    Staphylococcus lugdunensis7.33.61.27.37.37.3
    Staphylococcus warneri1.83.60.91.819.3 (8)14.5
    Stenotrophomonas maltophilia14.57.314.514.514.514.5
    • ↵a See Table 1 footnote for explanation of data.

PreviousNext
Back to top
Download PDF
Citation Tools
Transient and Sustained Bacterial Adaptation following Repeated Sublethal Exposure to Microbicides and a Novel Human Antimicrobial Peptide
Sarah Forbes, Curtis B. Dobson, Gavin J. Humphreys, Andrew J. McBain
Antimicrobial Agents and Chemotherapy Sep 2014, 58 (10) 5809-5817; DOI: 10.1128/AAC.03364-14

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transient and Sustained Bacterial Adaptation following Repeated Sublethal Exposure to Microbicides and a Novel Human Antimicrobial Peptide
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Transient and Sustained Bacterial Adaptation following Repeated Sublethal Exposure to Microbicides and a Novel Human Antimicrobial Peptide
Sarah Forbes, Curtis B. Dobson, Gavin J. Humphreys, Andrew J. McBain
Antimicrobial Agents and Chemotherapy Sep 2014, 58 (10) 5809-5817; DOI: 10.1128/AAC.03364-14
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596